Un. Das, ESSENTIAL FATTY-ACID METABOLISM IN PATIENTS WITH ESSENTIAL-HYPERTENSION, DIABETES-MELLITUS AND CORONARY HEART-DISEASE, Prostaglandins, leukotrienes and essential fatty acids, 52(6), 1995, pp. 387-391
Mortality and morbidity from coronary heart disease (CHD), diabetes me
llitus (DM) and essential hypertension (HTN) are higher in people of S
outh Asian descent than in other groups. There is evidence to believe
that essential fatty acids (EFAs) and their metabolites may have a rol
e in the pathobiology of CHD, DM and HTN. Fatty acid analysis of the p
lasma phospholipid fraction revealed that in CHD the levels of gamma-l
inolenic acid (GLA), arachidonic acid (AA), eicosapentaenoic acid (EPA
) and docosahexaenoic acid (DHA) are low, in patients with HTN linolei
c acid (LA) and AA are low, and in patients with non-insulin dependent
diabetes mellitus (NIDDM) and diabetic nephropathy the levels of diho
mo-gamma-linolenic acid (DGLA), AA, alapha-linolenic acid (ALA) and DH
A are low, all compared to normal controls. These results are interest
ing since DGLA, AA and EPA form precursors to prostaglandin E(1), (PGE
(1)), prostacyclin (PGI(2)), and PGI(3), which are potent platelet ant
i-aggregators and vasodilators and can prevent thrombosis and atherosc
lerosis. Further, the levels of lipid peroxides were found to be high
in patients with CHD, HTN, NIDDM and diabetic nephropathy. These resul
ts suggest that increased formation of lipid peroxides and an alterati
on in the metabolism of EFAs are closely associated with CHD, HTN and
NIDDM in Indians. Since insulin resistance and hyperinsulinemia and fe
atures of obesity, NIDDM, HTN and CHD, diseases that are common in Ind
ians, and as decreased insulin sensitivity is associated with decrease
d concentrations of polyunsaturated fatty acids (PUFAs) in skeletal mu
scle phospholipids and, possibly, in the plasma, the possibility is ra
ised that changes in the metabolism of EFAs may have a fundamental rol
e in the pathobiology of these conditions. If this is true, this sugge
sts that supplementation of GLA, DGLA, AA, EPA and/or DHA may be indic
ated to prevent CHD, HTN and NIDDM in Indians.